Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Apr-16 8:29 PM View:  | Adourian Aram S. SVP & Chief Scientific Officer | BG Medicine, Inc. (BGMD) | 31-Mar-16 | Payment of Exercise | 7,456 | $0.36 | $2,684.16 | (17%) 43.23K to 35.77K | 6% |
| 04-Apr-16 8:35 PM View: | Sohmer Paul R President & CEO Director | BG Medicine, Inc. (BGMD) | 31-Mar-16 | Payment of Exercise | 15,493 | $0.36 | $5,577.48 | (23%) 68.65K to 53.16K | 6% |
| 04-Apr-16 8:33 PM View: | Hall Stephen P EVP & Chief Financial Officer | BG Medicine, Inc. (BGMD) | 31-Mar-16 | Payment of Exercise | 8,986 | $0.36 | $3,234.96 | (22%) 40.02K to 31.03K | 6% |
| 11-Dec-15 4:23 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 09-Dec-15 | Market Sale | 2,508 | $0.56 | $1,404.48 | (< 1%) 1.29M to 1.29M | 39% |
| 11-Dec-15 4:23 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 09-Dec-15 | Market Sale | 43,930 | $0.56 | $24,600.80 | (3%) 1.33M to 1.29M | 39% |
| 19-Aug-15 8:22 PM View: | Adourian Aram S. SVP & Chief Scientific Officer | BG Medicine, Inc. (BGMD) | 15-Aug-15 | Payment of Exercise | 6,233 | $0.83 | $5,173.39 | (13%) 46.46K to 40.23K | 59% |
| 19-Aug-15 8:14 PM View: | Sohmer Paul R President & CEO Director | BG Medicine, Inc. (BGMD) | 15-Aug-15 | Payment of Exercise | 13,321 | $0.83 | $11,056.40 | (16%) 81.97K to 68.65K | 59% |
| 19-Aug-15 8:17 PM View: | Hall Stephen P EVP & Chief Financial Officer | BG Medicine, Inc. (BGMD) | 15-Aug-15 | Payment of Exercise | 7,505 | $0.83 | $6,229.15 | (16%) 47.5K to 39.99K | 59% |
| 29-Jul-15 4:46 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 27-Jul-15 | Exercise (in-the money or at-the-money) | 4,780 | $0.14 | $669.20 | < 1% 1.33M to 1.33M | |
| 29-Jul-15 4:41 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 27-Jul-15 | Market Sale | 4,980 | $2.27 | $11,304.60 | (< 1%) 1.33M to 1.33M | 85% |
| 29-Jul-15 4:46 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 27-Jul-15 | Market Sale | 302 | $2.27 | $685.54 | (< 1%) 1.33M to 1.33M | 85% |
| 29-Jul-15 4:41 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 27-Jul-15 | Exercise (in-the money or at-the-money) | 79,087 | $0.14 | $11,072.20 | 6% 1.25M to 1.33M | |
| 11-Dec-14 4:49 PM View: | Kania Edwin M Jr 10% Owner | BG Medicine, Inc. (BGMD) | 11-Dec-14 | Market Sale | 387,580 | $0.30 | $116,274.00 | (7%) 5.3M to 4.92M | 72% |
| 11-Dec-14 4:49 PM View: | Kania Edwin M Jr 10% Owner | BG Medicine, Inc. (BGMD) | 10-Dec-14 | Market Sale | 114,720 | $0.32 | $36,710.40 | (2%) 5.42M to 5.3M | 73% |
| 11-Dec-14 4:49 PM View: | Kania Edwin M Jr 10% Owner | BG Medicine, Inc. (BGMD) | 09-Dec-14 | Market Sale | 132,090 | $0.36 | $47,552.40 | (2%) 5.55M to 5.42M | 76% |
| 05-Dec-14 6:35 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 04-Dec-14 | Disposition (other) | 98,352 | -- | -- | (1%) 8.11M to 8.01M | |
| 05-Dec-14 6:40 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 04-Dec-14 | Disposition (other) | 703,655 | -- | -- | (9%) 7.97M to 7.27M | |
| 05-Dec-14 6:43 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 04-Dec-14 | Disposition (other) | 2,484,190 | -- | -- | (33%) 7.5M to 5.02M | |
| 05-Dec-14 6:45 PM View: | Kania Edwin M Jr 10% Owner | BG Medicine, Inc. (BGMD) | 04-Dec-14 | Acquisition (other) | 634,390 | -- | -- | 13% 4.92M to 5.55M | |
| 05-Dec-14 6:38 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 04-Dec-14 | Disposition (other) | 98,570 | -- | -- | (1%) 8.02M to 7.92M | |
| 05-Dec-14 6:43 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 04-Dec-14 | Acquisition (other) | 164,528 | -- | -- | 2% 7.33M to 7.49M | |
| 05-Dec-14 6:40 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 04-Dec-14 | Acquisition (other) | 11,190 | -- | -- | < 1% 7.96M to 7.97M | |
| 05-Dec-14 6:43 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 04-Dec-14 | Acquisition (other) | 10,029 | -- | -- | < 1% 7.49M to 7.5M | |
| 05-Dec-14 6:38 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 03-Dec-14 | Market Sale | 260 | $0.46 | $119.60 | (< 1%) 8.02M to 8.02M | 82% |
| 05-Dec-14 6:35 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 03-Dec-14 | Exercise (in-the money or at-the-money) | 6,483 | $0.02 | $138.94 | < 1% 8.1M to 8.11M | |
| 05-Dec-14 6:43 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 03-Dec-14 | Exercise (in-the money or at-the-money) | 51,240 | $0.02 | $1,024.80 | < 1% 7.28M to 7.33M | |
| 05-Dec-14 6:40 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 03-Dec-14 | Market Sale | 2,463 | $0.46 | $1,132.98 | (< 1%) 7.97M to 7.97M | 82% |
| 05-Dec-14 6:38 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 03-Dec-14 | Exercise (in-the money or at-the-money) | 6,536 | $0.02 | $140.70 | < 1% 8.01M to 8.02M | |
| 05-Dec-14 6:35 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 03-Dec-14 | Market Sale | 257 | $0.46 | $118.22 | (< 1%) 8.11M to 8.11M | 82% |
| 05-Dec-14 6:43 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 03-Dec-14 | Market Sale | 1,848 | $0.46 | $850.08 | (< 1%) 7.33M to 7.33M | 82% |
| 05-Dec-14 6:40 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 03-Dec-14 | Exercise (in-the money or at-the-money) | 54,558 | $0.02 | $1,331.58 | < 1% 7.92M to 7.97M | |
| 17-Oct-14 5:05 PM View: | Sohmer Paul R President & CEO Director | BG Medicine, Inc. (BGMD) | 16-Oct-14 | Grant | 327,900 | -- | -- | 100% 0 to 327.9K | |
| 17-Oct-14 5:07 PM View: | Hall Stephen P EVP & Chief Financial Officer | BG Medicine, Inc. (BGMD) | 16-Oct-14 | Grant | 190,200 | -- | -- | 100% 0 to 190.2K | |
| 17-Oct-14 5:10 PM View: | Adourian Aram S. SVP & Chief Scientific Officer | BG Medicine, Inc. (BGMD) | 16-Oct-14 | Grant | 157,800 | -- | -- | 563% 28.04K to 185.84K | |
| 04-May-16 6:15 PM View: | Adourian Aram S. SVP & Chief Scientific Officer | BG Medicine, Inc. (BGMD) | 14-Apr-14 | Option Exercise | 12,000 | $0.90 | $10,800.00 | 43% 28.04K to 40.04K | |
| 01-Feb-13 4:53 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 30-Jan-13 | Market Purchase | 2,000,000 | $2.00 | $4,000,000.00 | 32% 6.19M to 8.19M | (96%) |
| 01-Feb-13 4:50 PM View: | Papadopoulos Stelios Director | BG Medicine, Inc. (BGMD) | 30-Jan-13 | Market Purchase | 250,000 | $2.00 | $500,000.00 | 27% 937.71K to 1.19M | (96%) |
| 20-Nov-12 4:39 PM View: | Posner Brian S Director | BG Medicine, Inc. (BGMD) | 19-Nov-12 | Market Purchase | 10,000 | $1.16 | $11,650.00 | 100% 10.0K to 20.0K | (93%) |
| 19-Nov-12 4:21 PM View: | Bancel Stephane Executive Chairman Director | BG Medicine, Inc. (BGMD) | 15-Nov-12 | Market Purchase | 100,000 | $1.26 | $126,000.00 | 432% 23.17K to 123.17K | (93%) |
| 17-Sep-12 4:38 PM View: | Bancel Stephane Executive Chairman Director | BG Medicine, Inc. (BGMD) | 13-Sep-12 | Market Purchase | 1,381 | $3.70 | $5,109.70 | 6% 21.79K to 23.17K | (98%) |
| 22-Aug-12 4:21 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 21-Aug-12 | Disposition (other) | 298,137 | -- | -- | (5%) 6.48M to 6.19M | |
| 22-Aug-12 4:21 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 20-Aug-12 | Private Sale | 82 | $5.83 | $478.06 | (< 1%) 6.48M to 6.48M | |
| 22-Aug-12 4:21 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 20-Aug-12 | Exercise (in-the money or at-the-money) | 21,619 | $0.02 | $455.91 | < 1% 6.46M to 6.48M | |
| 11-Jun-12 8:08 PM View: | Muntendam Pieter EVP, Chief Medical Officer | BG Medicine, Inc. (BGMD) | 08-Jun-12 | Market Sale | 3,965 | $5.29 | $20,974.80 | (5%) 82.45K to 78.48K | 98% |
| 11-Jun-12 8:08 PM View: | Muntendam Pieter EVP, Chief Medical Officer | BG Medicine, Inc. (BGMD) | 07-Jun-12 | Market Sale | 30,021 | $5.50 | $165,116.00 | (27%) 112.47K to 82.45K | 98% |
| 01-Jun-12 4:56 PM View: | Muntendam Pieter EVP, Chief Medical Officer | BG Medicine, Inc. (BGMD) | 30-May-12 | Option Exercise | 100,000 | $0.90 | $90,000.00 | 802% 12.47K to 112.47K | |
| 23-May-12 5:18 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 23-May-12 | Disposition (other) | 130,867 | -- | -- | (2%) 6.59M to 6.46M | |
| 24-May-12 4:10 PM View: | Bouvier Eric President, CEO Director | BG Medicine, Inc. (BGMD) | 23-May-12 | Market Purchase | 10,000 | $3.95 | $39,500.00 | 100% 0 to 10.0K | (98%) |
| 23-May-12 9:17 PM View: | Posner Brian S Director | BG Medicine, Inc. (BGMD) | 22-May-12 | Market Purchase | 10,000 | $4.04 | $40,400.00 | 100% 0 to 10.0K | (98%) |
| 23-May-12 5:18 PM View: | Afeyan Noubar Director 10% Owner | BG Medicine, Inc. (BGMD) | 21-May-12 | Market Sale | 141 | $3.95 | $556.95 | (< 1%) 6.59M to 6.59M | 98% |
